(MTUM) iShares MSCI USA Momentum - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46432F3964
MTUM: Large, Cap, US, Momentum, Stocks
The iShares MSCI USA Momentum Factor ETF (MTUM) is designed to track the performance of the MSCI USA Momentum Index, which comprises US stocks that have demonstrated higher momentum relative to the broader MSCI USA Index. This is achieved by investing at least 80% of the funds assets in the constituent securities of the underlying index or in investments with similar economic characteristics.
By focusing on momentum, MTUM provides exposure to US stocks that have shown strong price performance, potentially capitalizing on trends and investor sentiment. The underlying index is constructed to overweight stocks with higher momentum, making it a potentially attractive option for investors seeking to tap into the growth potential of the US market.
Analyzing the available technical data, the current price of MTUM is $231.41, indicating a bullish trend as it is above its 20-day SMA ($228.44) and significantly above its 50-day and 200-day SMAs ($212.14 and $208.85, respectively). The Average True Range (ATR) of 3.58, or 1.55%, suggests moderate volatility. Given the 52-week high and low of $234.30 and $174.02, respectively, the ETF is currently near its all-time high, suggesting a strong uptrend.
With Assets Under Management (AUM) of $17.118 billion USD, MTUM demonstrates substantial investor interest and liquidity, making it a viable option for investors seeking exposure to the US momentum factor. The scale of the fund also implies that it can efficiently track its underlying index with minimal tracking error.
Forecasting future performance based on the available data, MTUM is likely to continue its upward trajectory if the momentum factor remains in favor. The ETFs proximity to its 52-week high and its position above key moving averages suggest potential for further growth, albeit with the risk of a pullback due to its near-all-time high valuation. Investors should monitor the ATR and price action relative to the SMA20 for signs of trend continuation or reversal. If the ETF can maintain its position above $228.44 and break through the $234.30 resistance, it may signal further upside potential.
Additional Sources for MTUM ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
MTUM ETF Overview
Market Cap in USD | 17,118m |
Category | Large Blend |
TER | 0.15% |
IPO / Inception | 2013-04-16 |
MTUM ETF Ratings
Growth Rating | 59.8 |
Fundamental | - |
Dividend Rating | 39.9 |
Rel. Strength | 7.04 |
Analysts | - |
Fair Price Momentum | 215.59 USD |
Fair Price DCF | - |
MTUM Dividends
Dividend Yield 12m | 0.79% |
Yield on Cost 5y | 1.44% |
Annual Growth 5y | 2.93% |
Payout Consistency | 90.6% |
Payout Ratio | % |
MTUM Growth Ratios
Growth Correlation 3m | 83.5% |
Growth Correlation 12m | 68.2% |
Growth Correlation 5y | 52.2% |
CAGR 5y | 13.99% |
CAGR/Max DD 5y | 0.43 |
Sharpe Ratio 12m | 2.11 |
Alpha | 5.54 |
Beta | 1.318 |
Volatility | 13.88% |
Current Volume | 1014.3k |
Average Volume 20d | 1017.9k |
As of June 15, 2025, the stock is trading at USD 230.26 with a total of 1,014,296 shares traded.
Over the past week, the price has changed by -1.07%, over one month by +1.23%, over three months by +17.34% and over the past year by +19.30%.
Partly, yes. Based on ValueRay´s Analyses, iShares MSCI USA Momentum (BATS:MTUM) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.75 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MTUM is around 215.59 USD . This means that MTUM is currently overvalued and has a potential downside of -6.37%.
iShares MSCI USA Momentum has no consensus analysts rating.
According to our own proprietary Forecast Model, MTUM iShares MSCI USA Momentum will be worth about 251.5 in June 2026. The stock is currently trading at 230.26. This means that the stock has a potential upside of +9.23%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 251.5 | 9.2% |